CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaulsky, G.
Right arrow Articles by Rotter, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaulsky, G.
Right arrow Articles by Rotter, V.

Cell Growth & Differentiation, Vol 2, Issue 12 661-667, Copyright © 1991 by American Association of Cancer Research


ARTICLES

Involvement of wild-type p53 protein in the cell cycle requires nuclear localization

G Shaulsky, N Goldfinger, A Peled and V Rotter
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Transfection of wild-type p53 into a pre-B, p53 nonproducer cell line yielded the generation of stable clones. Although constitutively expressing the growth-suppressor wild-type p53 protein, these cells proliferate continuously in vitro. However, expression of wild-type p53 in these cells altered their cell cycle pattern and reduced their growth in vivo. When the same parental cells were transfected with a plasmid coding for a wild-type p53 lacking nuclear localization signals, a wild-type cytoplasmic p53 protein was expressed. Expression of this cytoplasmic p53 product did not exert any changes in the growth of the parental cells, suggesting that wild-type p53 affects the cell cycle only when localized in the nuclear cell compartment.


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
K. Schuster, L. Fan, and L. C. Harris
MDM2 Splice Variants Predominantly Localize to the Nucleoplasm Mediated by a COOH-Terminal Nuclear Localization Signal
Mol. Cancer Res., April 1, 2007; 5(4): 403 - 412.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Mandic, C. J. Schamberger, J. F. Muller, M. Geyer, L. Zhu, T. E. Carey, R. Grenman, A. A. Dunne, and J. A. Werner
Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53
Clin. Cancer Res., October 1, 2005; 11(19): 6845 - 6852.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. P. McDonald, W. E. Hoy, G. P. Maguire, N. L. Duarte, D. E. L. Wilcken, and X. L. Wang
The p53Pro72Arg Polymorphism is Associated with Albuminuria among Aboriginal Australians
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 677 - 683.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. G. Moreno, B. Dutrillaux, and H. Coffigny
Status of p53, p21, mdm2, pRb Proteins, and DNA Methylation in Gonocytes of Control and {{gamma}}-Irradiated Rats During Testicular Development
Biol Reprod, May 1, 2001; 64(5): 1422 - 1431.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
J. Qiu, X. Li, G. Frank, and B. Shen
Cell Cycle-dependent and DNA Damage-inducible Nuclear Localization of FEN-1 Nuclease Is Consistent with Its Dual Functions in DNA Replication and Repair
J. Biol. Chem., February 16, 2001; 276(7): 4901 - 4908.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. L. Hughes, L. Gollapudi, T. L. Sladek, and K. E. Neet
Mediation of Nerve Growth Factor-driven Cell Cycle Arrest in PC12 Cells by p53: SIMULTANEOUS DIFFERENTIATION AND PROLIFERATION SUBSEQUENT TO p53 FUNCTIONAL INACTIVATION
J. Biol. Chem., December 1, 2000; 275(48): 37829 - 37837.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Rayanade, M. I. Ndubuisi, J. D. Etlinger, and P. B. Sehgal
Regulation of IL-6 Signaling by p53: STAT3- and STAT5-Masking in p53-Val135-Containing Human Hepatoma Hep3B Cell Lines
J. Immunol., July 1, 1998; 161(1): 325 - 334.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. L. Hughes, L. Gollapudi, T. L. Sladek, and K. E. Neet
Mediation of Nerve Growth Factor-driven Cell Cycle Arrest in PC12 Cells by p53: SIMULTANEOUS DIFFERENTIATION AND PROLIFERATION SUBSEQUENT TO p53 FUNCTIONAL INACTIVATION
J. Biol. Chem., December 1, 2000; 275(48): 37829 - 37837.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. Qiu, X. Li, G. Frank, and B. Shen
Cell Cycle-dependent and DNA Damage-inducible Nuclear Localization of FEN-1 Nuclease Is Consistent with Its Dual Functions in DNA Replication and Repair
J. Biol. Chem., February 16, 2001; 276(7): 4901 - 4908.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.